$13.80
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Country

IN

CEO

Mr. Erez Israeli

IPO date

1986

Employees

26,944

ISIN

INE089A01031

Key stats

Open

$13.60

Volume

5.12M

Market cap

$11.82B

Prev. close

$13.89

Impl / hst vl

-

Open interest

$0.00

$13.60

Day’s Range

$13.80

$12.19

52W Range

$15.67

Valuation

50
Valuation score
Fairly Valued
P/E
26.82
P/S
3.34
P/B
-
Current ratio
-
Debt / Equity
-
ROE
-
Gross margin
57.43%
Income growth
-81.74%
FCF growth
-

Aug

1

Dividends

The next payment date will be Aug 1, 2026

Div. per Share

$0.00

Div. Yield

0.59%

Payout Ratio

-

Div. Growth YoY

-0.09%

Analysts estimates

Consensus rating
Buy

The average rating from top 15 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$14.80
The top 39 analysts forecasts that 12-month price may increase by 7.27%, with a low of $11.35 and a high of $19.85
$11.35
Low
$14.80
Avg
$19.85
High
Current price

Earnings

Q1 ‘26 revenue
$790.03M
Q1 ‘26 net income
$23.13M
Revenue
Net income
Previous EPS
$0.17
Estimate EPS
$0.15
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply